dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUniv Calif San Diego
dc.date.accessioned2018-11-26T17:15:37Z
dc.date.available2018-11-26T17:15:37Z
dc.date.created2018-11-26T17:15:37Z
dc.date.issued2017-02-01
dc.identifierArtificial Cells Nanomedicine And Biotechnology. Abingdon: Taylor & Francis Ltd, v. 45, n. 1, p. 24-30, 2017.
dc.identifier2169-1401
dc.identifierhttp://hdl.handle.net/11449/162323
dc.identifier10.1080/21691401.2016.1241795
dc.identifierWOS:000391459800004
dc.description.abstractThere is a 0.138% incidence of adverse reactions related to blood transfusion. Transfusion-related acute lung injury, immunosuppression, fever, pathogen transmission, and hemolytic transfusion reactions are the most common ones. Synthetic oxygen carriers have been developed to deal with blood shortages and for use in the field where stored blood was not available. They were also designed to be pathogen free, including unknown viruses. In this study, we used Male Golden Syrian Hamsters implemented with a dorsal window chamber to determine how infusion of three different, genetically crosslinked recombinant acellular hemoglobin (rHb) solutions with different oxygen affinities and nitric oxide kinetics affect mean arterial pressure (MAP), heart rate (HR), kidney function, and kidney structure. We found that the administration of all three rHb solutions caused mild hypertension and bradycardia 30minutes after infusion. However, acute changes in glomerular filtration rate (GFR) were not detected, even though histological analysis was performed 72hours after treatment revealed some structural changes. All the rHb solutions resulted in hypertension 30minutes after a 10% topload administration. Regardless of their properties, the presence of acellular Hb causes significant alterations to kidney tissue.
dc.languageeng
dc.publisherTaylor & Francis Ltd
dc.relationArtificial Cells Nanomedicine And Biotechnology
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectBlood substitutes
dc.subjectglomerular filtration rate
dc.subjectfluorescein-isothiocyanate sinistrin
dc.subjectacute kidney injury
dc.titleAcute kidney function and morphology following topload administration of recombinant hemoglobin solution
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución